Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for prostate cancer.

J R Gingrich1, R D Chauhan, M S Steiner

  • 1Department of Urology, University of Tennessee Medical Center, 956 Court Avenue, H216, Memphis, TN 38163, USA. Jgingrich@utmem.edu

Current Urology Reports
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transgenic overexpression of endogenous FLOWERING LOCUS T-like gene MeFT1 produces early flowering in cassava.

PloS one·2020
Same author

An unusual case of axillary lymphadenopathy.

Medical journal, Armed Forces India·2015
Same author

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2013
Same author

Risk factors for concomitant involvement of the female urethra at cystectomy for malignancy.

Urologic oncology·2011
Same author

Molecular insights into altered cell cycle regulation and genitourinary malignancy.

Urologic oncology·2011
Same author

Prostate cancer cells lose their sensitivity to TGFβI growth inhibition with tumor progression.

Urologic oncology·2011

Gene therapy offers a novel approach to combat prostate cancer by targeting gene expression. While initial clinical trials show safety, further research is needed to confirm its long-term effectiveness in treating this malignancy.

Area of Science:

  • Molecular biology and oncology
  • Gene therapy applications in cancer treatment

Background:

  • Understanding the molecular basis of cancer progression, including cellular transformation, invasion, and metastasis.
  • The emergence of gene therapy as a potential strategy to modulate disease-causing genes.

Purpose of the Study:

  • To review preclinical research in gene therapy for prostate cancer.
  • To outline current therapeutic strategies and clinical trial outcomes for gene therapy in prostate cancer treatment.

Main Methods:

  • Review of recent preclinical studies on gene therapy for prostate cancer.
  • Analysis of current gene therapy approaches and strategies.
  • Compilation and summary of results from recent clinical trials.

Main Results:

Related Experiment Videos

  • Gene therapy has demonstrated relative safety in initial clinical trials for prostate cancer.
  • Definitive evidence of durable therapeutic efficacy for gene therapy in prostate cancer is still pending.
  • Preclinical research continues to explore novel gene-targeting mechanisms.

Conclusions:

  • Gene therapy is a promising but still developing field for prostate cancer treatment.
  • Ongoing research and clinical trials are crucial to establish the efficacy of gene therapy.
  • The safety profile of gene therapy in prostate cancer patients is encouraging for future development.